Evidence map›Paper›PMID 40028637›Full record

ArticlePublic health action2025

Assessing TB treatment outcomes in pregnant women living with HIV with drug-susceptible TB.

N Hernandez-Morfin, S Cohn, Z Waja, R E Chaisson, N Martinson, N Salazar-Austin

Abstract read
In one paragraph

Article in Public health action, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

N Hernandez-MorfinDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
S CohnDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Z WajaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
R E ChaissonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
N MartinsonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
N Salazar-AustinDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Pharmacology and Pharmacometrics CoreP30AI168436 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson, Petros C Karakousis · 2022 to 2026
$6.1M
Impact of TB on Outcome of HIV in Pregnant WomenR01HD064354 · NICHD · JOHNS HOPKINS UNIVERSITY · PI CHAISSON, RICHARD E. · 2010 to 2014
$3.0M
NIAID NIH HHS P30 AI094189NIAID NIH HHS P30 AI168436NICHD NIH HHS R01 HD064354
6 · The paper itself

Abstract

backgroundLimited data exist on TB treatment outcomes among pregnant women with TB. Physiological and immunological adaptations during pregnancy may affect the efficacy of TB treatment. We aimed to evaluate factors associated with unsuccessful TB treatment outcomes among pregnant women living with HIV (PWLHIV) and diagnosed with TB in the Tshepiso study.

methodsIn this secondary analysis, we used multivariable logistic regression to evaluate factors associated with unsuccessful TB treatment outcomes among PWLHIV with drug-sensitive TB disease enrolled in the Tshepiso study in Soweto, South Africa, from 2011-2014.

resultsThis analysis includes 79 PWLHIV diagnosed with drug-sensitive TB during pregnancy; 18 (23%) had an unsuccessful treatment outcome. Factors associated with unsuccessful TB treatment include detectable HIV RNA viral load at enrollment to the study (aOR 5.1, 95% CI 1.1-25.3), presence of extrapulmonary TB (aOR 2.2, 95% CI 0.4-11.7), bacteriological (positive smear and/or culture) confirmation of TB (aOR 2.1, 95% CI 0.7-6.7), and anemia (Hb ≤ 10.5 g/dL) (aOR 1.0, 95% CI 0.3-3.1). The only factor with statistical significance was a detectable HIV RNA viral load.

conclusionDetectable HIV viral load emerges as a critical factor associated with an unsuccessful TB treatment outcome in pregnant women living with HIV and diagnosed with TB.

Indexed as

maternal healthpregnancyTBTB-HIV co-infectiontreatment outcomestuberculosis

Identifiers

PMID40028637
PMCPMC11841118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.